GIA
AMRX icon

GHP Investment Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

GHP Investment Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18 Hold
1
– – ﹤0.01% 1389
2026
Q1 		$13 Buy
+1
New +$13 ﹤0.01% 1434

Other funds holding AMRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

GHP Investment Advisors's AMRX Position: Q2 2026 in Review

GHP Investment Advisors held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 1 share worth $18. The position accounts for ﹤0.01% of the portfolio, ranked #1389.

GHP Investment Advisors first reported a position in AMRX in Q1 2026 and has held it in 2 quarters since. 72 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • GHP Investment Advisors held 1 share of Amneal Pharmaceuticals worth $18 as of Q2 2026.
  • GHP Investment Advisors left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #1389 holding.
  • GHP Investment Advisors first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 72 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.